Cargando…
The diagnostic dilemma in a patient with neuroleptic malignant syndrome during the COVID‐19 pandemic: A significant increase in acute phase reactants
KEY CLINICAL MESSAGE: In some patients, neuroleptic malignant syndrome is accompanied significant high levels of erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP). ABSTRACT: Neuroleptic malignant syndrome (NMS) is an idiosyncratic life‐threatening adverse reaction and usually triggered...
Autores principales: | Elyasi, Forouzan, Zarghami, Mehran, Fariborzifar, Arghavan, Cheraghmakani, Hamed, Shirzad, Mahboobeh, Kazempour, Feteme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397481/ https://www.ncbi.nlm.nih.gov/pubmed/37546158 http://dx.doi.org/10.1002/ccr3.7734 |
Ejemplares similares
-
Olanzapine-Induced Neuroleptic Malignant Syndrome
por: Hosseini, Seyedhamze, et al.
Publicado: (2017) -
Neuroleptic Malignant Syndrome: Diagnostic and Therapeutic Dilemmas
por: Fekadu, Abebaw, et al.
Publicado: (2005) -
The management challenges of a case with Flupentixol‐induced neuroleptic malignant syndrome
por: Elyasi, Forouzan, et al.
Publicado: (2022) -
Catatonia versus neuroleptic malignant syndrome: the diagnostic dilemma and treatment
por: Sahoo, Manoj Kumar, et al.
Publicado: (2014) -
Carisoprodol withdrawal syndrome resembling neuroleptic malignant syndrome: Diagnostic dilemma
por: Paul, Gunchan, et al.
Publicado: (2016)